1. Home
  2. ADMA vs INFA Comparison

ADMA vs INFA Comparison

Compare ADMA & INFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • INFA
  • Stock Information
  • Founded
  • ADMA 2004
  • INFA 1993
  • Country
  • ADMA United States
  • INFA United States
  • Employees
  • ADMA N/A
  • INFA N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • INFA EDP Services
  • Sector
  • ADMA Health Care
  • INFA Technology
  • Exchange
  • ADMA Nasdaq
  • INFA Nasdaq
  • Market Cap
  • ADMA 5.8B
  • INFA 5.6B
  • IPO Year
  • ADMA N/A
  • INFA 2021
  • Fundamental
  • Price
  • ADMA $19.98
  • INFA $19.03
  • Analyst Decision
  • ADMA Strong Buy
  • INFA Buy
  • Analyst Count
  • ADMA 4
  • INFA 13
  • Target Price
  • ADMA $24.25
  • INFA $24.77
  • AVG Volume (30 Days)
  • ADMA 4.5M
  • INFA 3.5M
  • Earning Date
  • ADMA 05-07-2025
  • INFA 05-07-2025
  • Dividend Yield
  • ADMA N/A
  • INFA N/A
  • EPS Growth
  • ADMA N/A
  • INFA 215.78
  • EPS
  • ADMA 0.84
  • INFA 0.00
  • Revenue
  • ADMA $459,381,000.00
  • INFA $1,655,308,000.00
  • Revenue This Year
  • ADMA $18.45
  • INFA $5.30
  • Revenue Next Year
  • ADMA $26.96
  • INFA $5.91
  • P/E Ratio
  • ADMA $23.92
  • INFA $4,332.65
  • Revenue Growth
  • ADMA 62.23
  • INFA 2.29
  • 52 Week Low
  • ADMA $6.84
  • INFA $15.65
  • 52 Week High
  • ADMA $25.67
  • INFA $31.65
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 43.06
  • INFA 57.67
  • Support Level
  • ADMA $18.75
  • INFA $18.50
  • Resistance Level
  • ADMA $23.98
  • INFA $19.35
  • Average True Range (ATR)
  • ADMA 1.38
  • INFA 0.51
  • MACD
  • ADMA -0.34
  • INFA 0.13
  • Stochastic Oscillator
  • ADMA 17.77
  • INFA 78.66

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About INFA Informatica Inc.

Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.

Share on Social Networks: